In addition to donating stem cells for immediate use, stem cells can be banked for use in the future. Cells, such as cord blood stem cells, can be frozen at very low temperatures and stored in public banks for donation or in private banks, for personal or family use.
Organizations such as Be the Match have public cord banks, which can match this life-saving resource with patients in need. A list of public cord blood banks around the world can be found at Parents Guide to Cord Blood Foundation. At this time the Council of Europe European Committee on Organ Transplantation and the American Academy of Pediatrics recommend that families donate cord blood to public cord blood banks, rather than storing it in a private bank for biological insurance against a future issue.
If you choose to store cord blood in a private bank you should ensure that the bank has been accredited by a reputable organization, such as the AABB, an organization that sets international standards. To learn more about banking cord blood for public or private use see Cord Blood and Uses to Treat Disease: Private Banking vs Public Donation.
Patients should be aware that there are unscrupulous stem cell clinics that make false promises about stem cell therapies and promote banking stem cells for years, or even decades, for unproven future uses, if they can even be used at all. Additionally, any offered treatments could cause physical and financial harm. Typically, there are yearly storage fees at private banks, and this storage of cells for a potential treatment that has not yet been proven safe or effective can be costly.
Blood Stem Cells for Unproven Purposes
There are companies that promote banking adult blood stem cells for new, experimental personal uses. These companies claim that stem cells can be frozen when you are young and used later in life for "rejuvenation," or for treatments claiming to restore youthfulness and vitality. Currently, there is no evidence, however, that such a treatment would be effective in humans. The U.S. Food and Drug Administration issued a statement warning that infusing young blood into an older individual has no proven clinical benefit, and that it might in fact cause harm. More research is needed to determine whether transplanting young blood stem cells or blood products into older people can be safe and efficacious.
Consumers should be aware that banking adult blood stem cells for an indeterminate time can be expensive and that unproven stem cell treatments carry medical risk.
Mesenchymal Stromal Cells (MSCs)
A growing number of clinics and online companies advertise the use of mesenchymal stromal or stem cells (MSCs) for myriad unproven stem cell treatments. Companies try to convince consumers that they should collect and freeze these cells to have on hand to treat a long list of potential future diseases.
While legitimate mesenchymal stem cells were first discovered in bone marrow through rigorous scientific study, the cells that are typically marketed by clinics that promote unproven or unapproved treatments are a collection of mixed and undefined cells from a patients blood, fat, or bone marrow. These cells are marketed for stem cell or MSC therapies, but the biological properties and therapeutic potential of these uncharacterized cells is unknown, and claims of therapeutic benefit are not supported by sound science. Directly injecting these ill-defined cells into patients is currently controversial and requires further study.
Mesenchymal stem cells also have been reported to be isolated from other tissues, such as dental pulp, amniotic fluid, and cord blood. Some of these cells are thought to have stem cell properties and currently are being studied and may, at some point in the future, have application for disorders. However, there is no known benefit that currently has been identified.
There are multiple legitimate clinical trials underway testing the benefits of rigorously characterized MSCs to treat various diseases and conditions, but it is too early to know if there will be a scientifically proven therapeutic benefit.
Before banking any tissues or cells for a potential future MSC therapy, you should talk to a board certified and licensed physician who is unaffiliated with the stem cell bank or clinic, and is knowledgeable about the patients condition and the science behind the clinical application of stem cells. Banking these cells, and the treatments offered, can be expensive and there is little to no evidence to date to indicate that they are beneficial. In fact, in some cases they may cause harm.
T Cells
T cells are a type of immune cell that are being developed into a cancer therapy that shows great promise in treating various types of the disease. T cells can be collected from a patient and engineered to specifically attack cancer cells, while leaving other cells in the body unharmed. This technology is called chimeric antigen receptor T-cell (CAR-T) therapy. Several CAR-T therapies are approved to treat certain kinds of blood cancers, such as leukemia and lymphoma, in multiple countries and regions around the world.
Some companies are freezing patient T cells for potential future therapeutic use. These companies are making unfounded promises and are offering commercial services that are not fully developed. Additionally, the chances of acquiring one of the types of cancer that can be treated is low.
The International Society for Cell and Gene Therapy recently issued a statement warning patients against banking T cells for potential future use.
When evaluating any potential therapeutic intervention, you should ask questions and ensure to the extent possible that the treatment has been evaluated in an approved clinical trial, and that claims were tested through rigorous evidence-based science. Whether or not to donate or store stem cells for medical purposes is a personal decision, and you should always consult your doctor or a trusted medical professional.
If you are considering saving stem cells for a potential future stem cell therapy, refer to Nine Things to Know About Stem Cell Treatments to help inform your decision. If you are concerned that a stem cell clinic is providing unproven or unapproved stem cell treatments, you can refer to the How to Report False Marketing Claims and Adverse Events from Clinics Offering Unapproved Stem Cell Treatments.
Recommendations regarding stem cell banking and donation vary by cell type and treatment. Donated blood stem cells are an extremely valuable resource for patients who need blood stem cell transplantations to treat a variety of blood and immune system diseases. Physicians and patients should be aware, however, that there are unscrupulous private banks that make unsubstantiated claims about potential future uses of banked stem cells for other purposes. Before banking any cells for future use, patients should consult a physician and make sure that claims are supported by scientific data. For more information, see Stem Cell Treatments: What to Ask.
More here:
Cell Banking - About Stem Cells
- Stem Cell/Cord Blood Banking Market Size, Trend Analysis, Share, Competitive Analysis, And Forecast To 2033 - openPR - November 20th, 2024
- Medeze Group Reaffirms Its International Standards Degree of Stem Cell Banking Services - KAOHOON INTERNATIONAL - November 8th, 2024
- Adult Stem Cells Storage & Banking | Preserve Stem Cells Forever Labs - October 27th, 2024
- International Stem Cell Banking Initiative - October 27th, 2024
- SBS University hosts National Workshop on Stem Cell Banking - Garhwal Post - October 20th, 2024
- Stem Cell Banking Market Advancements and Opportunities in Cell Preservation and Research - openPR - October 18th, 2024
- The global leader in personal stem cell banking - October 15th, 2024
- Stem Cell Banking Outsourcing Industry to Witness Massive Growth (2024-2034) |CCBC, CBR, ViaCord, Esperite, Vcanbio, Boy Talented India - Talented... - October 15th, 2024
- Medeze, a stem cell banking service provider, will start trading on the Stock Exchange of Thailand on October 15 - Thailand Business News - October 15th, 2024
- Stem Cell Banking: Current Trends, Benefits, Emerging Issues and ... - October 14th, 2024
- Fundamental Principles of Stem Cell Banking - PubMed - October 11th, 2024
- Cell Bank Production - ATCC - October 10th, 2024
- Stem Cell Banking Market Size Projected to Reach USD 16.55 Billion, Globally, by 2030 at 15.6% CAGR - EIN News - October 10th, 2024
- The Growing Importance of Stem Cell Banking in the UAE - October 4th, 2024
- American Cell Technology | Stem Cell Banking in the United States - September 30th, 2024
- What to Know about Stem Cell Banking & Storage for Future Health - September 30th, 2024
- What is Stem Cell Banking? - azolifesciences.com - September 30th, 2024
- Stem Cell Banking Market Growth and Innovation 2024: Business - openPR - July 10th, 2024
- Stem Cell Banking Market Size To Surpass USD 19.29 Billion By 2030, Exhibiting A CAGR Of 13.69% As Revealed... - WhaTech - March 18th, 2024
- Stem Cell Banking Market Size, Share, Competitive Landscape and Trend Analysis and Industry Forecast, - EIN News - January 18th, 2024
- Stem Cell Banking Market Predicted to Witness Steady Growth ... - Digital Journal - September 8th, 2023
- Stem Cell Banking Market Expected To Reach $16.55 Billion by 2030 | CAGR 15.6% - EIN News - September 7th, 2023
- Stem Cell Banking Market Trends: Industry Analysis and Growth Projections Through 2030 - Benzinga - September 3rd, 2023
- Stem Cell Banking Market Report: Analysis of Effective Business ... - Digital Journal - August 30th, 2023
- Stem Cell Banking Market Expected To Reach $16.55 Billion by 2030 | CAGR of 15.6% - openPR - July 19th, 2023
- Stem Cell Banking Market expected to reach USD 16,474.30 million by 2029 - openPR - July 8th, 2023
- Global Stem Cell Banking Market is expected to reach a market size of ~US$ 15 billion by 2028: Ken Research - openPR - June 8th, 2023
- Stem Cell Banking Market: CAGR of 8.2% and Market Valuation ... - KaleidoScot - June 8th, 2023
- Cord Stem Cell Banking Market Size to Surpass USD 45.64 Billion with CAGR of 22% by 2030 - openPR - June 4th, 2023
- Forecasting the Future of the Stem Cell Banking Market : Trends and Insights | CCBC, Crioestaminal, Esperite, - openPR - April 29th, 2023
- Stem Cell Banking Market Expected To Reach $16.55 Billion by 2030 | Current Trends and Industry Analysis - EIN News - April 27th, 2023
- Stem Cell Banking Offers Health And Investment Opportunity - ValueWalk - April 21st, 2023
- Stem Cell Banking Offers Health and Investment Opportunity ... - SavingAdvice.com - April 19th, 2023
- Cord Stem Cell Banking Market to Influence the Value of USD 45.64 Billion by 2030 - openPR - April 12th, 2023
- Stem Cell Banking Market Size Expected to Reach USD 16,474.30 Million by 2029 with 16.1% CAGR - openPR - March 29th, 2023
- What is Stem Cell Banking? | Cells4Life - March 19th, 2023
- What is Stem Cell Banking? | Cells4Life - March 19th, 2023
- Stem Cell Banking Market Top-Players And Qualitative Future ... - Digital Journal - February 13th, 2023
- Global Stem Cell Banking Market Overview, Regional Analysis, Market Share and Competitive Analysis - openPR - February 4th, 2023
- What is Stem Cell Banking? | Stem Cell Preservation in India | Stem ... - January 7th, 2023
- Stem Cell & Cord Blood Banking Dubai, UAE - CellSave Arabia - January 5th, 2023
- Donate Stem Cells | Bone Marrow Donation - American Cancer Society - January 5th, 2023
- Private stem cell banking & genetic screening | Future Health Biobank - December 24th, 2022
- Stem Cell Banking Outsourcing Market is anticipated to expand at a ... - Digital Journal - December 20th, 2022
- Stem Cell Banking market size is estimated to be worth USD 1789 million in 2021 and is forecast to a readjuste - openPR - December 15th, 2022
- Stem Cell Banking Market To Reach USD 2927.2 Million By 2028 With A CAGR of 7.2% | Valuates Reports - Yahoo Finance - December 11th, 2022
- Stem Cell Banking Market registering a CAGR of 16.1% by forecast 2029 - openPR - December 1st, 2022
- Stem Cell Banking Industry 2022 - 2028 Market Analysis by Regions, Types and Application - openPR - November 6th, 2022
- Stem Cell Banking & Therapy In India | ReeLabs - October 25th, 2022
- Worldwide Stem Cell Banking Industry to 2027 - Rising Number of Fatal ... - October 25th, 2022
- Global Stem Cell Umbilical Cord Blood (UCB) Market Report 2022-2026: Increased Federal Investment in Stem Cell Therapy, and the Advent of Cord Blood... - October 25th, 2022
- Placental Stem Cell Therapy Market - Know the Latest Profit Sources of the Industry - openPR - October 18th, 2022
- Outlook on the Cord Blood Banking Services Global Market to 2027 - by Component, Storage Services, Application and Region - GlobeNewswire - October 13th, 2022
- Cell & Tissue Preservation Market Size will Observe Lucrative Surge by the End 2031 - openPR - October 12th, 2022
- News from the world of Education: October 12, 2022 - The Hindu - October 12th, 2022
- Stemcord | Home - October 9th, 2022
- Global Cord Blood Banking Market - Competition Forecast and Opportunities, 2027 - Yahoo Finance - October 9th, 2022
- Cell Banking Outsourcing Market Analysis By Trends, Size, Share, Company Overview, Growth And Forecast By 2031 The Colby Echo News - The Colby Echo... - October 4th, 2022
- Global Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman Islands - Business Wire - September 29th, 2022
- Biobanking Market Size to Surge at the CAGR of 5.9% from 2022-2031 - Digital Journal - September 19th, 2022
- Stem Cell Banking Solutions | Hope Biosciences - September 19th, 2022
- Stem Cell Therapy Market worth $558 million by 2027 Exclusive Report by MarketsandMarkets - Benzinga - September 17th, 2022
- Stem Cell Banking Market to Witness Massive Growth by 2029 | CCBC, CBR - Fighting Hawks Magazine - Fighting Hawks Magazine - September 15th, 2022
- Stem Cell Banking Market Analysis, 2031: Advancements in the field of Regenerative Medicine - BioSpace - September 15th, 2022
- Stem Cell Therapy Market worth $558 million by 2027 Exclusive Report by MarketsandMarkets - GlobeNewswire - September 15th, 2022
- Cord Blood Banking Services Market Size Estimated to Reach $3.6 Billion By 2027 at a CAGR of 11.8% During Forecast Period 2022-2027. - Digital Journal - August 30th, 2022
- Applied StemCell expands manufacturing facility to support cell and gene therapies - BioPharma-Reporter.com - August 30th, 2022
- What is Cord Blood Banking? - Benzinga - August 30th, 2022
- Vita 34 records moderate upward trend in the second quarter - PharmiWeb.com - August 30th, 2022
- dental stem cell banking - National Dental Pulp Laboratory - August 29th, 2022
- Global Cell Banking Outsourcing Market to Grow at a CAGR of ~18% during 2022-2031; Market to Expand Owing to the Development of Advanced Cell... - August 24th, 2022
- Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells - Nature.com - August 12th, 2022
- Stem cell therapy to be used in treatment of long COVID by Panacell Biotech - Labiotech.eu - August 10th, 2022
- Building a healthtech industry in Europe to serve patients - Labiotech.eu - August 9th, 2022
- Cell & Gene Therapy Manufacturing Services Market Research Report : With Healthy CAGR 7.8% : Will Reach USD 56.7 Billion by 2028 - Digital Journal - August 6th, 2022
- Oldest patient yet cured of HIV after stem cell transplant researchers - Global Banking And Finance Review - July 28th, 2022
- Stem Cell Banking Market Size to Accelerate at a Rapid CAGR of 16.1% from 2022 to 2029 - Digital Journal - July 25th, 2022
- Global Stem Cell Banking Outsourcing Market 2022 Trend Analysis, Growth Status, Revenue Expectation to 2028 This Is Ardee - This Is Ardee - July 19th, 2022
- Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million - Business Wire - July 14th, 2022
- Stem Cell Banking Market Detailed In New Research Report 2022 | Allergan, Plc., Galderma S.A., Integra LifeSciences Corporation, Merz Pharma GmbH... - July 12th, 2022
Recent Comments